NMTR
9 Meters Biopharma, Inc. Common Stock
NMTR
NMTR
Delisted
NMTR was delisted on the 25th of July, 2023.
98 hedge funds and large institutions have $81.7M invested in 9 Meters Biopharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+8
Holders Change %
+8.89%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
31
Reduced
14
Closed
25
Calls
$2.57M
Puts
$3M
Net Calls
-$438K
Net Calls Change
+$185K
Top Buyers
| 1 |
1
BlackRock
New York
|
$14.8M |
| 2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.48M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$3.27M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.71M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$12M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$9.42M |
| 2 |
TLP
2
Tri Locum Partners
New York
|
$0 |
| 3 |
CH
3
CVI Holdings
Wilmington,
Delaware
|
$0 |
| 4 |
MWNA
4
Marshall Wace North America
New York
|
$0 |
| 5 |
5
Citigroup
New York
|
$17K |
